Kolexia
Di Blasi Roberta
Hématologie
Hôpital Saint-Louis
Paris, France
87 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Lymphome B Tumeurs hématologiques COVID-19 Lymphome B diffus à grandes cellules Infections fongiques invasives Mycoses Aspergillose Leucémie aigüe myéloïde

Industries

Gilead
25 collaboration(s)
Dernière en 2023
Novartis
15 collaboration(s)
Dernière en 2023
Abbvie
4 collaboration(s)
Dernière en 2023
OPUSLINE
4 collaboration(s)
Dernière en 2021

Dernières activités

Feasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma.
Leukemia & lymphoma   09 décembre 2023
EPICOVIDEHA: Epidemiology of COVID-19 Infection in Patients With Hematological Malignancies: A European Haematology Association Survey
Essai Clinique (Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne)   21 novembre 2023
CD19-Targeting CAR T-Cell Therapy in Transformed Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma: A Descar-T and US Collaborative Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
Outcomes of High-Grade B-Cell Lymphoma As Compared to Other Large B-Cell Lymphoma Subtypes in Patients Treated with CD19-Directed CAR-T Cells at 3 rd Line or More. a Lysa Study Based on the French Descart-Registry.
65th ASH Annual Meeting Abstracts   02 novembre 2023
Low Tmtv Influences Response and Outcomes in R/R DLBCL 3L+ Patients Treated with CAR-T Cells : First Results of FDG-PET/CT Analysis in the French Descar-T Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Invasive Fungal Infections after CAR T-Cell Therapy for B-Cell Lymphoma: A Study from the French Descart Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Pourquoi la coordination des parcours de soins est encore plus essentielle aujourd'hui ?
Edimark   01 novembre 2023
Evolution des pratiques dans le service après l'arrivée des thérapies orales et des thérapies cellulaires
Edimark   01 novembre 2023
Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry.
Blood advances   01 novembre 2023
French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T)
Essai Clinique (Novartis)   25 septembre 2023